Baseline characteristics and mortality at end of follow-up among patients starting antiretroviral therapy in two cohorts in Zambia and Switzerland.

CIDRZ: Centre for Infectious Disease Research in Zambia; SHCS: Swiss HIV Cohort Study; IQR: interquartile range; d4T: stavudine; 3TC: lamivudine; NVP: nevirapine; AZT: zidovudine; EFV: efavirenz; ETC: emtricitabine; TNV: tenofovir; LPV: lopinavir. *Advanced: WHO stage III/IV or CDC clinical stage C.